|
|
|
|
| LEADER |
01483nam a22003255i 4500 |
| 001 |
000280596 |
| 005 |
20220117162304.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387345734
|
| 024 |
7 |
|
|a 10.1007/0-387-34573-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Fas Signaling /
|c edited by Harald Wajant.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
| 300 |
|
|
|a VIII, 160 p. 32 illus., 4 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Medical Intelligence Unit
|
| 505 |
0 |
|
|a FasL and Fas -- FasL-Independent Activation of Fas -- Role of Ceramide in CD95 Signaling -- Regulation of Fas Signaling by FLIP Proteins -- Fas-Induced Necrosis -- Fas—More Than an Apoptosis Inducer -- Retrograde Fas Ligand Signaling -- FasL and Fas in Liver Homeostasis and Hepatic Injuries -- Fas-Activation, Development and Homeostasis of T Cells -- The FasL-Fas System in Disease and Therapy -- Tools for Activation and Neutralization of Fas Signaling.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Wajant, Harald.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|